Special Issue "Cutaneous Reactions to Vaccination: Clinical and Histopathological Features"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 1149
Interests: dermatopathology; dermatology; skin diseases; skin tumors; soft tissue pathology; gynecopathology; neuropathology
Special Issues, Collections and Topics in MDPI journals
Special Issue in Current Oncology: Diagnosis of Solid and Hematological Tumours in the Era of Artificial Intelligence (AI)
Special Issue in Diagnostics: Current Issue and Perspectives in Dermatopathology
Special Issue in Cancers: Metastatic Cutaneous Neoplasms and Not Only: Current Knowledge and Perspectives
Special Issue in Journal of Imaging: Clinical and Pathological Imaging in the Era of Artificial Intelligence: New Insights and Perspectives
The advent of anti-SARS-CoV-2 mRNA vaccines has drastically reduced the morbidity and mortality associated with COVID-19, allowing a return to rather normal living conditions in a small number of months. Since the beginning of the vaccination campaign, vaccines have proven to be extremely effective in reducing complications during the disease, and there have been various reports of adverse events which, however, have been much lower than the benefits of vaccination. In this Special Issue, we intend to collect original articles, case reports, case series, reviews, and possible comments on this topic, with the hope of hosting scientific contributions that can stimulate discussion and herald new advances in this area.
Dr. Gerardo Cazzato
Dr. Francesca Ambrogio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- adverse reactions
- cutaneous manifestations